BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed at developing therapeutics in the breast ...

SAN FRANCISCO and SUZHOU, China, March 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...

Innovent Biologics has dosed the first subject in the randomised Phase III HeriCare-Ovarian01 trial of IBI354 for treating ...

Considering the acute mental illness she has been suffering from for years, SC Monday granted bail to one Pushpa Venaram ...

After being diagnosed with breast cancer in 2022, Amy Carswell had a ‘difficult experience’, but she has ‘come out the other ...

Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximately ...

Experts discuss how, discuss patient experiences with an oral chemotherapy regimen, highlighting benefits like treatment autonomy, challenges such as pill burden and gastrointestinal toxicities, and ...

Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...

The FDA has granted traditional approval to Keytruda (pembrolizumab) in combination with trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma.

The 68-year-old’s commute is now a bit easier since the University of Miami Health System expanded to Doral, one of the fastest growing cities in the state. While De Apodaca and his wife still have to ...